American Journal of Obstetrics & Gynecology
Volume 197, Issue 5 , Pages 486.e1-486.e10, November 2007

Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes

Presented at the Pediatric Academic Society Meeting, San Francisco, CA, May 1, 2006.

  • Sanjiv B. Amin, MD

      Affiliations

    • Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY
    • Corresponding Author InformationReprints: Sanjiv B. Amin, MD, Assistant Professor of Pediatrics, Golisano Children’s Hospital at Strong, P.O. Box 651, 601 Elmwood Ave, Rochester, NY 14642
  • ,
  • Robert A. Sinkin, MD, MPH

      Affiliations

    • Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY
  • ,
  • J. Christopher Glantz, MD, MPH

      Affiliations

    • Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, NY.

Received 8 January 2007; received in revised form 23 February 2007; accepted 14 April 2007.

Objective

The objective of the study was to determine whether indomethacin used as a tocolytic agent is associated with adverse neonatal outcomes.

Study Design

We used published guidelines of the Metaanalysis of Observational Studies in Epidemiology Group (MOOSE) to perform the metaanalysis. The search strategy used included computerized bibliographic searches of MEDLINE (1966-2005), PubMed (1966-2005), abstracts published in Obstetrics and Gynecology (1991-2005), abstracts published in Pediatric Research (1991-2005), and references of published manuscripts. Study inclusion criteria were publication in English, more than 30 deliveries less than 37 weeks’ gestation, and meeting diagnostic criteria for individual neonatal outcomes. Exclusion criteria included case reports, case series, and multiple publications from the same author. Metaanalysis was performed using random effects model if there were more than 2 observational studies for a specific outcome. Eggers test was performed to exclude publication bias. Sensitivity analysis was performed to evaluate the effect of antenatal steroid exposure, gestation, and recent antenatal indomethacin exposure (duration of 48 hours or more between the last dose and delivery).

Results

Fifteen retrospective cohort studies and 6 case-controlled studies met inclusion criteria. Antenatal indomethacin was associated with an increased risk of periventricular leukomalacia (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.3-3.1). Recent exposure to antenatal indomethacin was associated with necrotizing enterocolitis (OR, 2.2; 95% CI; 1.1-4.2). Antenatal indomethacin was not associated with intraventricular hemorrhage, patent ductus arteriosus, respiratory distress syndrome, bronchopulmonary dysplasia, and mortality.

Conclusion

Antenatal indomethacin may be associated with an increased risk of periventricular leukomalacia and necrotizing enterocolitis in premature infants and therefore should be used judiciously for tocolysis.

Key words: antenatal indomethacin, metaanalysis of observational studies, necrotizing enterocolitis, periventricular leukomalacia, premature infants

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The study was performed as part of a clinical investigational training toward a master’s degree in clinical research and was funded by K-23 National Institutes of Health Grant DC 06229.Cite this article as: Amin SB, Sinkin RA, Glantz JC. Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes. Am J Obstet Gynecol 2007;197:486.e1-486.e10.

PII: S0002-9378(07)00540-6

doi:10.1016/j.ajog.2007.04.019

American Journal of Obstetrics & Gynecology
Volume 197, Issue 5 , Pages 486.e1-486.e10, November 2007